Skip to content

Trends in Tuberculosis Preventive Therapy Prescribing Among People Living with HIV in South Africa, 2005-2022.

Sep 2026 · Journal of Acquired Immune Deficiency Syndromes · 0 citations
Medicine

TL;DR

Over 2005-2022, TPT prescribing shifted markedly toward initiation near the time of ART initiation, with early prescribing exceeding 70% by 2022, underscoring the need for targeted catch-up strategies.

View source

Similar papers

Open access 2026

Factors Associated With Tuberculosis Preventive Therapy Uptake among Eligible Children under Fifteen Years at Kakamega County Referral Hospital, Kenya

Background: Tuberculosis (TB) remains a significant global health concern, with efforts aimed at ending the epidemic by 2035. Tuberculosis Preventive Therapy (TPT) is a key intervention to prevent progression from latent TB infection to active disease, especially in children under fifteen, who were at higher risk parti...

Jackson K. Limo, David Masinde, S. Korir · 0 citations
Open access Jan 2026

Tuberculosis Incidence and Predictors Among People Living With HIV After Isoniazid–Rifapentine (3HP) Preventive Therapy in Ethiopia: A Retrospective Cohort Study

Significant risk factors for TB incidence among HIV‐positive individuals were identified, highlighting the need for targeted preventive strategies to address these risks, particularly in high‐risk populations.

E. Etu, Edao Wajiso Kallo, Kelil Husen Lenbo et al. · 0 citations
Open access Oct 2026

High Initiation but Suboptimal Completion of Tuberculosis-Preventive Treatment Among People Living With HIV on Antiretroviral Therapy, Persistent Tuberculosis Incidence, and Programmatic Implications: Findings From a 2-Year Multicountry Cohort Study

Abstract Background Tuberculosis-preventive treatment (TPT) is recommended for those at risk of tuberculosis, but despite encouraging trial data, evidence of its effectiveness from routine settings with diverse TPT regimens is limited. We describe routine TPT implementation outcomes in people living with human immunode...

L. Chimoyi, S. Ginindza, B. Nonyane et al. · 0 citations
Review Open access Jan 2026

Tuberculosis Treatment Uptake and Outcomes Among HIV-Positive Patients on Antiretroviral Therapy at a Tertiary Health Facility in South-South, Nigeria

Background There is a significant intersection between Tuberculosis (TB) and HIV, which has contributed greatly to the disease burden, especially in Nigeria. Among approximately 1.9 million people living with HIV (PLHIV), an estimated 46,000 also had TB in 2019 alone. HIV-associated TB incidence has continuously increa...

A. Aigbokhaode, A. Jegede, N. Orhue et al. · 0 citations
Open access Oct 2026

Tuberculosis preventive treatment and care cascade among household contacts of patients starting tuberculosis treatment in Southern Africa: a multicountry cohort analysis

Abstract Background Tuberculosis preventive treatment (TPT) is recommended for household contacts of tuberculosis (TB) patients, yet implementation gaps persist, particularly in high-burden settings. We evaluated the TB preventive care cascade and determinants of TPT initiation among household contacts of patients with...

Leticia Wüthrich, G. Muula, D. Evans et al. · 0 citations
Open access Sep 2026

Scaling-up tuberculosis preventive therapy to HIV-negative contacts of bacteriologically confirmed TB cases aged 5 years and above – Lessons from a tuberculosis preventive therapy surge activity in Zambia

While tuberculosis preventive therapy (TPT) coverage among people living with HIV in Zambia has improved, uptake among HIV-negative contacts aged ≥5 years remains low. Despite evidence showing that TPT can reduce TB incidence by up to 60% in HIV-negative individuals, there is a paucity of evidence on programmatic rollo...

P. Mwaba, I. Mwaba, M. Maimbolwa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.